Artificial Intelligence in Oncology Drug Discovery and Development / John W. Cassidy, Belle Taylor.
There exists a profound conflict at the heart of oncology drug development. The efficiency of the drug development process is falling, leading to higher costs per approved drug, at the same time personalised medicine is limiting the target market of each new medicine. Even as the global economic bur...
Saved in:
| TeilnehmendeR: | |
|---|---|
| Place / Publishing House: | [s.l.] : : IntechOpen,, 2020. |
| Year of Publication: | 2020 |
| Language: | English |
| Physical Description: | 1 online resource (1 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 02134nam a22004337a 4500 | ||
|---|---|---|---|
| 001 | 993544754204498 | ||
| 005 | 20240301163337.0 | ||
| 006 | m o d | ||
| 007 | cr#u|||||||||| | ||
| 008 | 211214p20202020xx o u00| u eng d | ||
| 020 | |a 1-78985-898-4 | ||
| 024 | 8 | |a https://doi.org/10.5772/intechopen.88376 | |
| 035 | |a (CKB)5490000000052458 | ||
| 035 | |a (ScCtBLL)e7b3ced1-1aa0-4c44-9f10-c6bdd14cdc2c | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/29768 | ||
| 035 | |a (EXLCZ)995490000000052458 | ||
| 040 | |a ScCtBLL |c ScCtBLL | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Cassidy, John W. |4 edt | |
| 245 | 0 | 0 | |a Artificial Intelligence in Oncology Drug Discovery and Development |c John W. Cassidy, Belle Taylor. |
| 260 | |c 2020 | ||
| 264 | 1 | |a [s.l.] : |b IntechOpen, |c 2020. | |
| 300 | |a 1 online resource (1 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | 0 | |a Description based on print version record. | |
| 506 | |a Open access |f Unrestricted online access |2 star | ||
| 520 | |a There exists a profound conflict at the heart of oncology drug development. The efficiency of the drug development process is falling, leading to higher costs per approved drug, at the same time personalised medicine is limiting the target market of each new medicine. Even as the global economic burden of cancer increases, the current paradigm in drug development is unsustainable. In this book, we discuss the development of techniques in machine learning for improving the efficiency of oncology drug development and delivering cost-effective precision treatment. We consider how to structure data for drug repurposing and target identification, how to improve clinical trials and how patients may view artificial intelligence. | ||
| 540 | |f CC BY-NC | ||
| 546 | |a English | ||
| 536 | |a Knowledge Unlatched | ||
| 650 | 7 | |a Computers / Artificial Intelligence |2 bisacsh | |
| 650 | 0 | |a Computers | |
| 653 | |a Computers | ||
| 653 | |a Artificial Intelligence | ||
| 653 | |a General | ||
| 700 | 1 | |a Cassidy, John W. |e editor. | |
| 700 | 1 | |a Taylor, Belle |e editor. | |
| 906 | |a BOOK | ||
| ADM | |b 2024-03-02 08:12:37 Europe/Vienna |f system |c marc21 |a 2021-02-25 14:04:33 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337718790004498&Force_direct=true |Z 5337718790004498 |b Available |8 5337718790004498 | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5339616770004498&Force_direct=true |Z 5339616770004498 |b Available |8 5339616770004498 | ||